 Arthritis, Rheumatoid
"Arthritis, Rheumatoid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
| Descriptor ID |
D001172
|
| MeSH Number(s) |
C05.550.114.154 C05.799.114 C17.300.775.099 C20.111.199
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Arthritis, Rheumatoid".
Below are MeSH descriptors whose meaning is more specific than "Arthritis, Rheumatoid".
This graph shows the total number of publications written about "Arthritis, Rheumatoid" by people in this website by year, and whether "Arthritis, Rheumatoid" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 9 | 0 | 9 | | 1997 | 6 | 0 | 6 | | 1998 | 8 | 2 | 10 | | 1999 | 10 | 2 | 12 | | 2000 | 6 | 2 | 8 | | 2001 | 13 | 1 | 14 | | 2002 | 14 | 3 | 17 | | 2003 | 10 | 1 | 11 | | 2004 | 13 | 0 | 13 | | 2005 | 11 | 5 | 16 | | 2006 | 16 | 3 | 19 | | 2007 | 8 | 2 | 10 | | 2008 | 6 | 1 | 7 | | 2009 | 25 | 1 | 26 | | 2010 | 36 | 2 | 38 | | 2011 | 18 | 2 | 20 | | 2012 | 18 | 0 | 18 | | 2013 | 39 | 3 | 42 | | 2014 | 28 | 0 | 28 | | 2015 | 27 | 1 | 28 | | 2016 | 31 | 3 | 34 | | 2017 | 24 | 1 | 25 | | 2018 | 27 | 0 | 27 | | 2019 | 28 | 4 | 32 | | 2020 | 28 | 2 | 30 | | 2021 | 26 | 3 | 29 | | 2022 | 30 | 0 | 30 | | 2023 | 30 | 0 | 30 | | 2024 | 30 | 5 | 35 | | 2025 | 25 | 2 | 27 | | 2026 | 9 | 0 | 9 |
To return to the timeline, click here.
Below are the most recent publications written about "Arthritis, Rheumatoid" by people in Profiles.
-
Mantel I, Zhang H, Vargas J, Ce G, Townsend H, Bell R, Lakhanpal A, Fein MR, Norman TM, Orange DE, Ramirez DC, DiCarlo EF, Goodman SM, Smith MH, Zhang F, Wei K, Dey KK, Rudensky AY, Leslie CS, Donlin LT. SPP1hi macrophages in fibrin niches promote hyperplastic tissue remodeling in rheumatoid arthritis synovium. Sci Transl Med. 2026 Jun 24; 18(855):eaed3087.
-
McDougle DR, Moon JJ, Fox DA. Myeloid-Derived Suppressor Cells in Inflammatory Arthritis. Int J Mol Sci. 2026 Jun 14; 27(12).
-
Holers VM. The evolving landscape of complement therapeutics in rheumatology. Ann Rheum Dis. 2026 Jun; 85(6):969-983.
-
Deane KD, Striebich CC, Feser ML, O'Dell JR, James JA, Sparks JA, Davis JM, Graf J, McMahon MA, Solow EB, Forbess LJ, Tiliakos A, Schiopu E, Danila MI, Horowitz DL, Kay J, Strickland CD, Guthridge JM, Arriens C, Grossman JM, Kristen Demoruelle M, Bemis EA, Frazer-Abel A, Fleischer CL, Fox DA, Mikuls TR, Greenleaf M, York K, Walker S, Keyes-Elstein L, Byron M, Fedler J, Goldmuntz EA, Holers VM. A Phase 2 Trial of Hydroxychloroquine in Individuals at Risk for Rheumatoid Arthritis. Arthritis Rheumatol. 2026 Apr; 78(4):809-820.
-
Qureshi S, Adas M, Cope PJ, Mahfouz H, Bechman K, Deane KD, El-Gabalawy H, Emery P, Finckh A, Gilbert BTP, Holers VM, Isaacs JD, Kastbom A, Mankia K, Mikuls TR, Pratt AG, Rech J, Russell MD, Schett G, Trouw LA, Turesson C, Beers-Tas MHV, van der Helm-van Mil AHM, van Schaardenburg D, van Steenbergen HW, Toes REM, Cope AP, Galloway J, Norton S. Autoantibodies as predictors of progression to rheumatoid arthritis: a systematic review and meta-analysis. RMD Open. 2026 02 11; 12(1).
-
Hawkins JA, Curtis JR, Weinberg A, Siegel SAR, Huffstutter JE, Loveless J, Gharib S, Reddy S, Sinha J, Ridley D, Messaoudi I, Park JK, Lee EB, Winthrop KL. Safety and immunogenicity of the recombinant zoster vaccine in patients with rheumatoid arthritis using abatacept: a pilot multicentre, double-blind, randomised controlled trial. Ann Rheum Dis. 2026 May; 85(5):787-796.
-
Carlson DJ, Nichols LM, Moreland LW. Emerging Therapeutics in Rheumatoid Arthritis. Curr Rheumatol Rep. 2026 Jan 31; 28(1):2.
-
Shaikh FS, Shanta MA, Singh AK, Daniels AM, Khuder SA, Thiele GM, Reed GW, Kremer JM, Pappas DA, Curtis JR, O'Dell JR, Ouseph MM, Fox DA, Ahmed S. TWEAK receptor (Fn14) exacerbates TNF-a-induced inflammation in rheumatoid arthritis synovial fibroblasts and influences response to anti-TNF-a therapy. Cell Mol Immunol. 2026 Mar; 23(3):315-328.
-
Bhamidipati K, McIntyre ABR, Kazerounian S, Ce G, Wong SW, Tran M, Prell SA, Lau R, Khedgikar V, Altmann C, Small A, Madhu R, Presti SR, Anufrieva KS, Blazar PE, Lange JK, Seifert JA, Moreland LW, Croft AP, Smith MH, Donlin LT, Lewis MJ, Jonsson AH, Pitzalis C, Thomas R, Gravallese EM, Brenner MB, Korsunsky I, Wechalekar MD, Wei K. Spatial patterning of fibroblast TGFß signaling underlies treatment resistance in rheumatoid arthritis. Nat Immunol. 2026 Mar; 27(3):556-571.
-
Ormsby AL, Matson SM, Griffith MR, Demoruelle MK, Lee JS. Subclinical Interstitial Lung Disease in Rheumatoid Arthritis: Implications for Early Detection and Management. Chest. 2026 Apr; 169(4):1018-1025.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|